Outcome of pemphigus vulgaris

Journal of the European Academy of Dermatology and Venereology

Volumn 22, Issue 5, 2008, Pages 580-584

  Kavusi, S ^a   Daneshpazhooh, M ^a   Farahani, F ^a   Abedini, R ^a   Lajevardi, V ^a   Chams davatchi, C ^a  

^a UNIVERSITY OF TEHRAN   (Iran)

Author keywords

Mucocutaneous; Pemphigus vulgaris; Remission; Subtypes

Indexed keywords

AZATHIOPRINE; PREDNISOLONE;

ADULT; ARTICLE; CONTROLLED STUDY; DRUG DOSE REDUCTION; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MUCOSAL DISEASE; PEMPHIGUS VULGARIS; PRIORITY JOURNAL; RELAPSE; REMISSION; RETROSPECTIVE STUDY; STATISTICAL ANALYSIS; TREATMENT OUTCOME;

ADULT; AZATHIOPRINE; DISEASE PROGRESSION; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; FEMALE; GLUCOCORTICOIDS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; PEMPHIGUS; PREDNISOLONE; RECURRENCE; RETROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME;

EID: 42149189378     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2007.02537.x     Document Type: Article

References (22)

1. Yoshida K, Takae Y, Saito H et al. Cutaneous type pemphigus vulgaris: A rare clinical phenotype of pemphigus. J Am Acad Dermatol 2005; 52: 839-845.
2. Amagai M, Tsunoda K, Zillikens D, Nagai T, Nishikawa T. The clinical phenotype of pemphigus is defined by the anti-desmoglein autoantibody profile. J Am Acad Dermatol 1999; 40: 167-170.
3. Jamora MJ, Jiao D, Bystryn JC. Antibodies to desmoglein 1 and 3, and the clinical phenotype of pemphigus vulgaris. J Am Acad Dermatol 2003; 48: 976-977.
4. Chams-Davatchi C, Valikhani M, Daneshpazhooh M et al. Pemphigus: analysis of 1209 cases. Int J Dermatol 2005; 44: 470-476.
5. Harman KE, Albert S, Black MM. Guidelines for the management of pemphigus vulgaris. Br J Dermatol 2003; 149: 926-937.
6. Asilian A, Yoosefi A, Faghini G. Pemphigus vulgaris in Iran: epidemiology and clinical profile. Skinmed 2006; 5: 69-71.
7. Salmanpour R, Shahkar H, Namazi MR, Rahman-Shenas MR. Epidemiology of pemphigus in south-western Iran: A 10-year retrospective study (1991-2000). Int J Dermatol 2006; 45: 103-105.
8. Harman KE, Seed PT, Gratian MJ, Bhogal MS, Challacombe SL, Black MM. The severity of cutaneous and oral pemphigus is related to desmoglein 1 and 3 antibody levels. Br J Dermatol 2001; 144: 775-780.
9. Nagasaka A, Matsue H, Miyahara A, Shimada S. Pemphigus vulgaris with no mucosal lesions showing pemphigus-foliaceus-like skin manifestations: Is there a 'cutaneous type'of pemphigus vulgaris? Dermatology 2005; 211: 372-374.
10. Bystryn JC, Rudolph JL. Pemphigus. Lancet 2005; 366: 61-73.
11. Alsaleh QA, Nanda A, Al-Baghli NM, Dvorak R. Pemphigus in Kuwait. Int J Dermatol 1999; 38: 351-356.
12. Uzun S, Durdu M, Akman A et al. Pemphigus in the Mediterranean region of Turkey: A study of 148 cases. Int J Dermatol 2006; 45: 523-528.
13. Chams-Davatchi C, Esmaili N, Daneshpazhooh M et al. Randomized controlled open-label trial of four treatment regimens for pemphigus vulgaris. J Am Acad Dermatol 2007.
14. Samadi Z, Gorouhi F, Davari P, Firooz A. Think globally, act locally: Expert opinions from Asia on the diagnosis and treatment of pemphigus vulgaris. Indian J Med Sci 2007; 61: 144-151.
15. Brenner S, Tur E, Shapiro J et al. Pemphigus vulgaris: Environmental factors. Occupational, behavioral, medical, and qualitative food frequency questionnaire. Int J Dermatol 2001; 40: 562-569.
16. Ahmed AR, Moy R. Death in pemphigus. J Am Acad Dermatol 1982; 7: 221-228.
17. Bystryn JC, Steinman NM. The adjuvant therapy of pemphigus. An update. Arch Dermatol 1996; 132: 203-212.
18. Smolle J. [Therapy of pemphigus. Critical remarks based on 44 clinical cases]. Hautarzt 1985; 36: 96-102.
19. Herbst A, Bystryn JC. Patterns of remission in pemphigus vulgaris. J Am Acad Dermatol 2000; 42: 422-427.
20. Savin JA. Some factors affecting prognosis in pemphigus vulgaris and pemphigoid. Br J Dermatol 1981; 104: 415-420.
21. Scully C, Paes De Almeida O, Porter SR, Gilkes JJ. Pemphigus vulgaris: the manifestations and long-term management of 55 patients with oral lesions. Br J Dermatol 1999; 140: 84-89.
22. Seidenbaum M, David M, Sandbank M. The course and prognosis of pemphigus. A review of 115 patients. Int J Dermatol 1988; 27: 580-584.